Literature DB >> 2866629

[Eutopic and ectopic hormone formation in the APUD endocrine cell system].

J Blahos, J Jensovský.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2866629

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN： 0042-773X


× No keyword cloud information.
  14 in total

1.  Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer.

Authors:  Shuo Wang; Yuan Qu; Pengyan Xia; Yi Chen; Xiaoxiao Zhu; Jing Zhang; Guan Wang; Yong Tian; Jianming Ying; Zusen Fan
Journal:  Cell Res       Date:  2020-05-04       Impact factor: 25.617

2.  PRSS8 suppresses colorectal carcinogenesis and metastasis.

Authors:  Yonghua Bao; Yongchen Guo; Yiqiong Yang; Xiaonan Wei; Shanshan Zhang; Yongmeng Zhang; Kai Li; Ming Yuan; Dongli Guo; Virgilia Macias; Xiangdong Zhu; Wei Zhang; Wancai Yang
Journal:  Oncogene       Date:  2018-08-16       Impact factor: 9.867

3.  Tumor Necrosis Factor α Reduces SNAP29 Dependent Autolysosome Formation to Increase Prion Protein Level and Promote Tumor Cell Migration.

Authors:  Huan Li; Ren Wang; Ze Yu; Run Shi; Jie Zhang; Shanshan Gao; Ming Shao; Shuzhong Cui; Zhenxing Gao; Jiang Xu; Man-Sun Sy; Chaoyang Li
Journal:  Virol Sin       Date:  2020-11-25       Impact factor: 4.327

4.  Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer.

Authors:  Keunyoung Kim; Kyoungjune Pak; In-Joo Kim; Mijin Kim; Bo Hyun Kim; Byung-Joo Lee; Seong-Jang Kim
Journal:  Endocrine       Date:  2020-05-05       Impact factor: 3.633

5.  MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.

Authors:  Jingjing Li; Tianjie Pu; Lijuan Yin; Qinlong Li; Chun-Peng Liao; Boyang Jason Wu
Journal:  Oncogene       Date:  2020-02-17       Impact factor: 9.867

6.  A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience.

Authors:  J Watanabe; M Saito; Y Horimoto; S Nakamoto
Journal:  Breast Cancer Res Treat       Date:  2020-04-05       Impact factor: 4.872

Review 7.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

8.  The COX-2/PGE2 pathway suppresses apical elimination of RasV12-transformed cells from epithelia.

Authors:  Nanami Sato; Yuta Yako; Takeshi Maruyama; Susumu Ishikawa; Keisuke Kuromiya; Suzumi M Tokuoka; Yoshihiro Kita; Yasuyuki Fujita
Journal:  Commun Biol       Date:  2020-03-18

Review 9.  Comparing the effects of different cell death programs in tumor progression and immunotherapy.

Authors:  Michelle N Messmer; Annelise G Snyder; Andrew Oberst
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

Review 10.  The prognostic role of the pre-treatment neutrophil to lymphocyte ratio (NLR) and tumor depth of invasion (DOI) in early-stage squamous cell carcinomas of the oral tongue.

Authors:  Giovanni Salzano; Giovanni Dell'Aversana Orabona; Vincenzo Abbate; Luigi Angelo Vaira; Umberto Committeri; Paola Bonavolontà; Pasquale Piombino; Fabio Maglitto; Camilla Russo; Daniela Russo; Silvia Varricchio; Federica Attanasi; Mario Turri-Zanoni; Giacomo de Riu; Luigi Califano
Journal:  Oral Maxillofac Surg       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.